Finance and Investment Committee
The Finance and Investment Committee oversees the preparation and monitoring of the Institute’s budget on behalf of the Governing Body.
This work includes advising on the number and value of our biomedical research grants each year.
The Committee’s other main role is monitoring the Lister Institute’s investments and maintaining regular contact with our two investment managers, Cazenove Capital and Partners Capital LLP, who each have responsibility for the day-to-day management of one half of the total portfolio.
The Lister Institute’s Finance and Investment Committee ensures that we remain financially sustainable and independent, giving us the freedom to support the development of a high quality biomedical research environment in the UK and Republic of Ireland.
The members of the Finance and Investment Committee are:
Mr Murray Legg, BSc, FCA – Treasurer and Chairman of the Finance and Investment Committee
Murray is a chartered accountant who spent 35 years with PricewaterhouseCoopers until retiring in 2013. As a partner with PwC he held a variety of senior management, governance and client facing roles auditing and advising large UK listed and unlisted companies. He was a member of the PwC international network’s Global Governance Board, and he also served on the PwC UK firm’s governance body. Murray is a non-executive director of GlobalData plc and of Sutton and East Surrey Water plc and chairs these companies’ audit committees.
Professor John Iredale, BM (Hons), DM, FRCP (Lond), FRCP (Ed), FMedSci, FRSE, MAE – Chairman
John took on the role of Chairman of the Lister Institute of Preventive Medicine in 2022. He is currently on secondment from the University of Bristol, where he holds the Chair of Experimental Medicine, to UKRI where he is the interim Executive Chair of the MRC. His research interests are focused on tissue scarring and regeneration and he has published extensively on these subjects. Professor Iredale was, in the past, the Regius Chair of Medical Science, Dean of Clinical Medicine and Vice Principal Health Services at the University of Edinburgh where he led the Medical School.
Professor Judith Armitage, PhD, FRS, University of Oxford
Judy is a bacterial physiologist, with a particular interest in bacterial movement. After a PhD then Lister Fellowship from UCL she moved to the Biochemistry Department at University of Oxford. She was Associate Head of Microbiology and Director of the Systems Biology Centre. She is a member of EMBO, a Fellow of the American Academy of Microbiology, the European Academy of Microbiology and the Royal Society, where she sits on the Council. She is currently President of the Microbiology Society.
The Hon Rory Guinness BA, FCIM, representative of Lord Iveagh
Rory currently chairman of the Iveagh Trust and has a background in investment management at senior level. He wrote “The World of Guinness” and regularly speaks on matters to do with the history of the family, the brewery and philanthropy. He also sits on the Boards of St Patrick’s Cathedral, The European Movement Ireland and Rory Guinness Experiences, which provides visitors to the British Isles with unique experiences.
Mr Stephen McMahon, MA (Oxon), FCA, FCSI
Stephen is a Director of ARC Group and is responsible for the company’s Jersey office. After reading Economics & Management at Oxford University, Stephen qualified as an accountant with Pricewaterhouse Coopers in London before joining the Bank of England, where he reviewed operations in the Economic and Financial Markets divisions of the central bank. Stephen is a Chartered Fellow of both the Institute of Chartered Accountants (ICAEW) and the Chartered Institute for Securities and Investment (CISI).
Mr Matthew Pintus, BA
Matthew is a solicitor. He was a partner for many years at Macfarlanes, the Institute’s lawyers, and now works as an independent consultant for families in the UK and elsewhere, giving general advice including advice on their charitable activities.